A risk score model to predict in-hospital mortality of patients with end-stage renal disease and acute myocardial infarction

被引：0
作者：
Yuan Fu
Hao Sun
Zongsheng Guo
Li Xu
Xinchun Yang
Lefeng Wang
Kuibao Li
Mulei Chen
Yuanfeng Gao
机构：
[1] Chaoyang Hospital,Department of Cardiology
[2] Capital Medical University,undefined
来源：
Internal and Emergency Medicine | 2021年 / 16卷
关键词：
Risk score model; Acute myocardial infarction; Chronic kidney disease; End-stage renal disease; Continuous renal replacement therapy; The GRACE risk score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Chronic kidney disease (CKD) significantly increases the rate of adverse cardiovascular events in patients with coronary artery disease. In this study, we aimed to establish a risk score (RS) model to predict in-hospital mortality risk in patients with end-stage renal disease (ESRD) and acute myocardial infarction (AMI). A total of 113 consecutive patients with ESRD and AMI were retrospectively enrolled between January 1, 2015 and December 31, 2019. All patients received regular hemodialysis and were divided into two groups according to the prognosis during hospitalization. Univariable and multivariable logistic regression analyses were used to identify the risk factors of in-hospital mortality. A RS model was developed based on multiple regression analysis and was internally validated using 1000 bootstrap analysis. The receiver operating characteristic (ROC) curve was performed, and the area under curve (AUC) was analyzed to evaluate the performance of the RS model. AUCs were compared using the Z test. Thirty-three patients died during hospitalization, resulting in in-hospital mortality rate of 29.2%. After multivariate logistic regression, an RS model (0–8) was established based on five independent factors that were assigned with different points according to relative coefficients (coefficient of the index risk factor divided by the lowest coefficient among these five risk factors; rounded to closest integer): 1 for C-reactive protein (CRP) ≥ 14.2 mg/L and left ventricular ejection fraction (LVEF) ≤ V3%; 2 for age ≥ 65 years old, heart rate (HR) at admission ≥ 86 beats per minute (bpm) and d-dimer ≥ 2.4 mg/L FEU. The present RS model had a sensitivity of 85.7%, the specificity of 84%, and an accuracy of 78.1%. In ROC curve analysis, the model demonstrated a good discriminate power in predicting in-hospital mortality (AUC = 0.895, 95% CI 0.814–0.96; P < 0.001), which was significantly better than the predictive power of the Global Registry of Acute Coronary Events risk score (GRACE RS) (AUC = 0.754, 95% CI 0.641–0.868; P < 0.001 after Z test). A novel RS model, which was established to help predict in-hospital mortality of patients with ESRD and AMI, was easy to use and had higher accuracy than the GRACE RS.
引用
收藏
页码：905 / 912
页数：7
相关论文
共 299 条
[11]  
Favarato D(2018)In-hospital mortality analysis of Japanese patients with acute coronary syndrome using the Tokyo CCU Network database: applicability of the GRACE risk score J Cardiol 333 1091-2353
[12]  
Linhares-Filho JPP(2006)Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 163 2345-1617
[13]  
Martins EB(2003)Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 34 1613-64
[14]  
Batista DV(2018)Accuracy of the Global Registry Of Acute Coronary Events (GRACE) risk score in contemporary treatment of patients with acute coronary syndrome Can J Cardiol 58 59-349
[15]  
Rezende PC(2003)Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions Catheter Cardiovasc Interv 171 342-808
[16]  
Hueb AC(2017)Development and internal validation of a clinical risk score for treating children with mild head trauma and intracranial injury JAMA Pediatr 355 799-2126
[17]  
Ramires JAF(2006)Development and validation of a risk score for predicting death in Chagas’ heart disease N Engl J Med N Engl J Med 168 2120-223
[18]  
Kalil-Filho R(2013)Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score Int J Cardiol 70 212-130
[19]  
Smilowitz NR(2014)Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point Biometrics 54 120-114
[20]  
Gupta N(2016)Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care Eur J Cancer 29 109-1982
12345678910